Pharma Taking Open Innovation Medicine
The website Opinno notes that open innovation is the model that pharma companies are turning to now as a replacement to the traditional model which is based on developing R&D from their own basement laboratories, i.e, closed innovation. Once open innovation is adopted, the organization’s boundaries become permeable which allows for the combining of company resources with the external co-operators.
Click here to read the full article.